SCHEMBL2428197

SCHEMBL2428197

CN(C(=O)OC(C)(C)C)[C@@H]1CCCNC1=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
CCR2 P41597 7/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ASGR1 P07306 1/20 0.34
PSEN1 P49768 4/20 0.34
PSEN2 P49810 4/20 0.34
APH1B Q8WW43 4/20 0.34
NCSTN Q92542 4/20 0.34
APH1A Q96BI3 4/20 0.34
PSENEN Q9NZ42 4/20 0.34
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.33
BUB1 O43683 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428195 1.00 DDB1 (0.40) DDB1CRBNCCR2L3MBTL1ASGR1
SCHEMBL4186725 0.95 CCR2 (0.44) DDB1CRBNCCR2L3MBTL1PSEN1
SCHEMBL4186722 0.95 CCR2 (0.44) DDB1CRBNCCR2L3MBTL1PSEN1
SCHEMBL17770853 0.84 CCR2 (0.44) DDB1CRBNCCR2PSEN1PSEN2
SCHEMBL12527633 0.81 CCR2 (0.43) DDB1CRBNCCR2PSEN1PSEN2
SCHEMBL12494656 0.79 MEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2709823 0.79 MEN1 (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4188392 0.77 L3MBTL1 (0.44) CCR2L3MBTL1PSEN1PSEN2APH1B
SCHEMBL1059501 0.77 DDB1 (0.35) DDB1CRBNASGR1HSD11B1KMT2A
SCHEMBL7375997 0.76 DDB1 (0.37) DDB1CRBNCCR2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2550274-A1 PYRROLOPYRAZINE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP disclosed
WO-2011117160-A1 PYRROLOPYRAZINE DERIVATIVES AND THEIR USE AS JAK AND SYK INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2011-09-29 WO disclosed